
MD MPH, PGY-4, Chief Resident IM @Lahey_Clinic | GI Research @Lahey_Clinic |MD @Themsubaroda| Public health @BUSPH
Joined July 2013
- Tweets212
- Following1.1K
- Followers263
- Likes4.7K
Neev Mehta retweeted
Finally, a global consensus on #ACLF criteria and severity !
It will help large-scale observational studies and better international clinical trials.
@EASLnews @AASLDtweets @APASLnews @alehlatam @Solda_Society
Neev Mehta retweeted
Why do some UC patients fail vedolizumab (VDZ)?
A landmark study in Nature Medicine by Schreiber et al. unpacks the biological mechanism of VDZ resistance: revealing an alternative vascular bypass that might be targetable with common medications
🏔️ Taking liver research to new heights—literally!
Had a great #TLM2026 in Denver with a Poster of Distinction and an Oral Presentation!
Beyond grateful to the Lahey Transplant team and my amazing mentors for helping me reach new heights! 🩺✨
#AASLD #LaheyTransplant
Neev Mehta retweeted
Wrapping up the last day at #TLM2026 after presenting one poster and one oral abstract 🎤📊 It’s been a productive and memorable meeting. So grateful to the Lahey team and all my mentors for their support along the way 🧡👏
Neev Mehta retweeted
📢 Catch our LFN members presenting their exciting research today at TLM!
🗓️ Thursday, Nov 5
⏰ 12–1 PM MT
📍 Poster Session
Stop by, support your colleagues, and join the conversation! 👏
#AASLD #LiverTwitter
Neev Mehta retweeted
At the RA-MD 11th Meeting 2026, presented a unique case- advanced fibrotic ILD with coexisting IPAF and short telomere syndrome.
🧬Telomere biology disorders are an underrecognized cause of progressive fibrotic ILD. Watch for early onset, rapid decline, and premature graying.
Neev Mehta retweeted
🚨 Update to OMIGuide!
Huge shoutout to Mriganka Nerkar, MS4, who led a major expansion of the guide - adding 100+ new cases from Dr. Smith’s ECG Blog since our original launch in 2023!
Check out the updates at omiguide.org
@smithECGBlog @PendellM @WillyFrick
What an excellent thread for new trainees looking to do research in residency!
1/ My first paper in PGY2 residency landed in JAMA Oncology, and the truth is it was won before I ran a single analysis. It came down to how I chose the question. 8 Years later, I realized that very few trainees got taught about how to pick a first research idea. Lets try a bit
1
210
Neev Mehta retweeted
1/ My first paper in PGY2 residency landed in JAMA Oncology, and the truth is it was won before I ran a single analysis. It came down to how I chose the question. 8 Years later, I realized that very few trainees got taught about how to pick a first research idea. Lets try a bit
Had a gut feeling this poster would land well. #DDW2026 Chicago edition
2023: nervous first-timer with a poster 📄 2026: still nervous, but in Chicago 🏙️
Both times: walked away inspired, humbled, and with new connections and ideas.
#Grateful #GITwitter #Gastroenterology
Neev Mehta retweeted
Finally someone’s done this study pubmed.ncbi.nlm.nih.gov/4148…
Neev Mehta retweeted
Prophylaxis of SBP is dying
But if you still insist, then please do NOT continue the same antibiotic after an episode of SBP. This happens 80% of the time according to a new study. Bananas!!! Just because cipro is in the guidelines does not mean it’s the only one you can use.
Neev Mehta retweeted
Cirrhosis is diagnosed too late.
Routine ECG + AI can do more than assess the heart in primary care, now in @NatureMedicine
🫀15,596 patients with ECG
🏥Pragmatic randomized trial
📈Increased detection of liver disease
💡Scalable, low-cost screening
nature.com/articles/s41591-0…
Neev Mehta retweeted
Data are very weak.
doi.org/10.1093/cid/ciaf047
Time to rethink SBP prophylaxis?
Antibiotic prophylaxis for SBP in cirrhosis has been standard since the 1990s—but the new 🔥ASEPTIC trial, presented at #TLM25, just challenged that.
📊 Bactrim vs placebo in cirrhosis + ascites (no prior SBP):
➡️ No survival benefit for primary prophylaxis
Maybe it’s time to revisit this long-standing practice!
Neev Mehta retweeted
Loved interacting with residents and diving into all things endoscopy! Thank you @AmCollegeGastro @IBD_Afzali for the opportunity! #GITwitter #MedTwitter #ACG2025
The tradition continues!
✅ ACG 2022
✅ ACG 2024
✅ ACG 2025
Grateful for another incredible #ACG experience — learning, connecting, and being inspired by the brightest minds in GI.
Leaving more empowered and motivated than ever!
#Gastroenterology #MedTwitter #ACG2025
Neev Mehta retweeted
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
Neev Mehta retweeted
Perioperative risk assessment and management in patients with cirrhosis: new clinical guidelines from @AmCollegeGastro 🆕✂️
📸: journals.lww.com/ajg/fulltex…












































